Communications Biology · 2022 · 20 citations · 19 references
Life SciencesImmunologyInfectious DiseasesAntibody EngineeringMolecular VirologyVirologyAntibody Fragment EngineeringAntiviral ImmunityAntiviral TherapyViral InfectionsAntibody-mediated Viral NeutralizationAntiviral TherapeuticsRecombinant Fusion ProteinsSars-cov-2 Antiviral TherapySars-cov-2 InfectionTreatment Of Coronavirus InfectionsViral Fusion ProteinsViral Spike Proteins
Coronavirus infections are a world-wide threat to human health. A promising strategy to develop a broadly active antiviral is the use of fusion proteins consisting of an antibody IgG Fc region and a human ACE2 domain to which the viral spike proteins bind. Here we create antiviral fusion proteins based on IgM scaffolds. The hexameric ACE2-IgM-Fc fusions can be efficiently produced in mammalian cells and they neutralize the infectious virus with picomolar affinity thus surpassing monomeric ACE2-IgM-Fc by up to 96-fold in potency. In addition, the ACE2-IgM fusion shows increased neutralization efficiency for the highly infectious SARS-CoV-2 omicron variant in comparison to prototypic SARS-CoV-2. Taken together, these multimeric IgM fusions proteins are a powerful weapon to fight coronavirus infections.
19
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Wenhui Li, Michael J. Moore, Natalya Vasilieva et al. · Nature · 2003 · 6.3K citations · Full text
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian et al. · Nature · 2021 · 2.1K citations · Full text
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
Changhai Lei, Kewen Qian, Li Tian et al. · Nature Communications · 2020 · 432 citations · Full text